WCE 2019: Safety of Holmium Laser Enucleation of the Prostate in the Outpatient Setting
Based on their established hematuria/urine clarity protocol, 90% of patients were able to be discharged home the day of surgery. 5 patients required overnight observation and were discharged the following day. They compared age, prostate volume, retention rate, enucleated tissue, and enucleation time between patients discharged on the same day and patients requiring overnight observation. There were no statistically significant differences. At a 3-month follow-up, there was a statistically significant improvement in AUA symptom score, QoL score, Qmax, and PVR compared to baseline.
In conclusion, 10% of patients required overnight observation for continued bladder irrigation according to their hematuria protocol. Of the patients requiring observation, the maximum stay was 1 day. The authors concluded that HoLEP performed as an outpatient surgery is safe and feasible in selected patients.
Presented by: Deepak K. Agarwal, MD, Endourology Fellow, Indiana University, Mayo Clinic, Rochester, Minnesota
Written by: Pengbo Jiang, MD, Department of Urology, University of California, Irvine at the 37th World Congress of Endourology (WCE) – October 29th-November 2nd, Abu Dhabi, United Arab Emirates